1 – 10 of 20
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
The C-type lectin of the aggrecan g3 domain activates complement.
(
- Contribution to journal › Article
-
Mark
COMP-C3b Complexes in Rheumatoid Arthritis with Severe Extraarticular Manifestations.
(
- Contribution to journal › Article
-
Mark
Cartilage oligomeric matrix protein-induced complement activation in systemic sclerosis
(
- Contribution to journal › Article
- 2012
-
Mark
Serum COMP-C3b complexes in rheumatic diseases and relation to anti-TNF-alpha treatment
(
- Contribution to journal › Article
-
Mark
Interactions of the complement system with molecules of extracellular matrix: Relevance for joint diseases.
(
- Contribution to journal › Article
-
Mark
PRELP Protein Inhibits the Formation of the Complement Membrane Attack Complex
(
- Contribution to journal › Article
- 2011
-
Mark
Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: Implications for multiple myeloma
(
- Contribution to journal › Article
-
Mark
The NC4 domain of the cartilage-specific collagen IX inhibits complement directly due to attenuation of membrane attack formation and indirectly through binding and enhancing activity of complement inhibitors C4B-binding protein and factor H.
(
- Contribution to journal › Article
- 2010
-
Mark
Inflammation and joint disease: Molecules/fragments that are released upon cartilage breakdown can activate complement and provide a new diagnostics for pathological complement activation
(
- Contribution to journal › Published meeting abstract
-
Mark
The NC4 domain of the cartilage-specific collagen IX is a novel complement inhibitor
(
- Contribution to journal › Published meeting abstract